Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Opioid Treatment Surge Act This bill requires the Department of Health and Human Services to assess market-share-based fees, for the next 10 years, on drug manufacturers that have produced opioid drugs since 1999. Opioid drugs manufactured to treat opioid addiction, cancer patients, or hospice patients are, however, exempt from this assessment. All assessed fees must be used for the substance abuse prevention and treatment block grant program.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2020 · fourth_quarter · Health Issues
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Client expense: $209,625 · Firm income: Not reported
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE